Retrospective Study
Copyright ©The Author(s) 2016.
World J Hepatol. Dec 8, 2016; 8(34): 1502-1510
Published online Dec 8, 2016. doi: 10.4254/wjh.v8.i34.1502
Table 2 Statistical analysis of prognostic factors with respect to disease-free survival
Demographic, clinical and pathological factorsSurvival [median (range) mo]Uni-variate analysis
Demographic factors
Age0.099
< 65 yr (n = 43)6 (3-36)
≥ 65 yr (n = 28)12 (2-36)
Gender0.343
Male (n = 50)6 (3-36)
Female (n = 21)5 (2-36)
Presentation0.755
Synchronous (n = 35)6 (2-36)
Metachronous (n = 36)6 (3-36)
Surgical factors
Less than hemi-hepatectomy (n = 49)6 (2-36)0.760
Hemi-hepatectomy or more (n = 22)6 (2-36)
Histo-pathological factor
Largest tumour size0.813
< 5 cm (n = 60)6 (2-36)
≥ 5 cm (n = 11)9 (2-36)
No. of metastases0.538
< 4 (n = 44)7 (2-36)
> 5 (n = 27)6 (3-36)
Lymphatic invasion0.256
Positive (n = 15)6 (2-24)
Negative (n = 56)6 (2-36)
Vascular invasion0.775
Positive (n = 28)6 (2-36)
Negative (n = 43)7 (2-36)
Peri-neural invasion0.115
Positive (n = 9)6 (2-24)
Negative (n = 62)6 (2-36)
Biliary invasion0.919
Positive (n = 25)6 (2-36)
Negative (n = 46)6 (2-36)
Resection margin (R0)0.017
R0 (n = 40)8 (2-36)
R1 (n = 31)6 (2-36)